Journal Mobile Options
Table of Contents
Vol. 11, No. 1, 2005
Issue release date: 2005
Eur Addict Res 2005;11:22–31

Evaluation of the Drug Use Disorders Identification Test (DUDIT) in Criminal Justice and Detoxification Settings and in a Swedish Population Sample

Berman A.H. · Bergman H. · Palmstierna T. · Schlyter F.
aCenter for Health Equity Studies, Stockholm University/Karolinska Institutet, Department of Psychology, Stockholm University; bDepartment of Clinical Neuroscience, Karolinska Institutet; cNEUROTEC, Karolinska Institutet, and dSwedish Prison and Probation Administration, Stockholm, Sweden

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Psychometric properties of the 11-item self-report Drug Use Disorders Identification Test (DUDIT) were evaluated in a sample of heavy drug users from prison, probation, and inpatient detoxification settings, and in a general Swedish population sample. In the drug user sample, the DUDIT predicted drug dependence with a sensitivity of 90% for both DSM-4 and ICD-10 and a respective specificity of 78 and 88%. Reliability according to Cronbach’s α coefficient was 0.80. In the population sample, 3.1% scored positive on the DUDIT; T-score values are suggested. The DUDIT screens effectively for drug-related problems in clinically selected groups and may prove useful in the context of public health surveys.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Skinner HA: The drug abuse screening test. Addict Behav 1982;7:363–371.
  2. Hoffman NG, Hunt DE, Rhodes WM, Riley KJ: UNCOPE: A brief substance dependence screen for use with arrestees. J Drug Issues 2003;33:29–44.
  3. Brown RL, Rounds LA: Conjoint screening questionnaires for alcohol and other drug abuse: Criterion validity in a primary care practice. Wisc Med J 1995;94:135–140.
  4. Ali R, Awwad E, Babor T, et al: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction 2002;97:1183–1194.
  5. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG: AUDIT, the Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. Geneva, WHO, 2001.
  6. WHO: Schedules for Clinical Assessment in Neuropsychiatry, Version 2.1: Interview, Glossary and Code Book. Geneva, WHO, Division of Mental Health, Assessment, Classification and Epidemiology, 1999.
  7. Bransome M: Authorized Swedish translation of WHO (1998) Schedules for Clinical Assessment in Neuropsychiatry, chapters 11 and 12, Use of Psychoactive Substances. Stockholm, Karolinska Institutet, 1999.
  8. WHO: Schedules for Clinical Assessment in Neuropsychiatry, I-shell computer program; in ed 2.1. Geneva, WHO, Division of Mental Health, Assessment, Classification and Epidemiology, 2001.
  9. Tabachnick B, Fidell S: Using Multivariate Statistics, ed 3. New York, Harper Collins, 1996.
  10. Nunnally JC: Psychometric Theory, ed 2. New York, McGraw-Hill, 1978.
  11. Magnusson D: Testteori (Test Theory). Stockholm, Psykologiförlaget AB, 1961/2003.
  12. Sveriges befolkning 31 december 2002 (Sweden’s population as of December 31, 2002). Accessed September 15, 2003, at
  13. Anastasi A: Psychological Testing. New York, MacMillan, 1988.
  14. Bergman H, Källmén H: Alcohol use among Swedes and a psychometric evaluation of the Alcohol Use Disorders Identification Test. Alcohol and Alcoholism 2002;37:245–251.
  15. Bergman H, Källmén H: Befolkningens alkoholvanor enligt AUDIT-testet (Alcohol use in the Swedish population according to the AUDIT). Läkartidningen (J Swed Med Assoc) 2000;97:2078–2084.
  16. Hasin D, Grant BF, Cottler L, et al: Nosological comparisons of alcohol and drug diagnoses: A multisite, multi-instrument international study. Drug Alcohol Depend 1997;47:217–226.
  17. Fritzell J, Lundberg O: Välfärd, ofärd och ojämlikhet – levnadsförhållanden under 1990-talet (Welfare, disadvantage and inequality – living conditions during the 1990s). Stockholm, Socialdepartmentet (Ministry of Health and Social Affairs), 2000, Report No SOU 2000:41.
  18. Hvitfeldt T: Skolelevers drogvanor 2002 (Schoolchildren’s drug habits 2002). Stockholm, CAN – Swedish Council for Information on Alcohol and Other Drugs (, 2003.
  19. Guttormsson U: Mönstrandes drogvanor 2002 (Military conscripts’ drug habits 2002). Stockholm, CAN – Swedish Council for Information on Alcohol and Other Drugs (, 2003.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50